Home » Stock Quotes » CVE:ARCH

Arch Biopartners Inc CVE:ARCH

Today's live share price, quote history, chart & news

0.92 CAD
+0.02 (2.22%)
Price open 0.91
Previous close 0.90
Market cap 55.09M
Volume 20.30K
Day high 0.92
Day low 0.90
Year high 1.38
Year low 0.74

About Arch Biopartners Inc

Arch Biopartners Inc., a biotechnology company, develops technologies for improving the health of patients. The company develops AB569, a drug candidate for the treatment of antibiotic resistant bacterial infections, primarily in the lungs and wounds, as well as to treat pseudomonas aeruginosa infections in the respiratory tracts of patients with cystic fibrosis. It also develops MetaBlok, a drug candidate for the treatment of sepsis, cancer metastasis, and inflammation based diseases. In addition, the company develops Borg, a Peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules target brain tumor initiating cells and invasive glioma cells. Arch Biopartners Inc. is headquartered in Toronto, Canada.

Name Arch Biopartners Inc
Exchange TSX Venture Exchange
Sector Healthcare
Industry Biotechnology
Country Canada

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.